TY - JOUR
T1 - Calpain regulates enterocyte brush border actin assembly and pathogenic Escherichia coli-mediated effacement
AU - Potter, David A.
AU - Srirangam, Anjaiah
AU - Fiacco, Kerry A.
AU - Brocks, Daniel
AU - Hawes, John
AU - Herndon, Carter
AU - Maki, Masatoshi
AU - Acheson, David
AU - Herman, Ira M.
PY - 2003/8/8
Y1 - 2003/8/8
N2 - This study identifies calpain as being instrumental for brush border (BB) microvillus assembly during differentiation and effacement during bacterial pathogenesis. Calpain activity is decreased by 25-80% in Caco 2 lines stably overexpressing calpastatin, the physiological inhibitor of calpain, and the effect is proportional to the calpastatin/calpain ratio. These lines exhibit a 2.5-fold reduction in the rate of microvillus extension. Apical microvillus assembly is reduced by up to 50%, as measured by quantitative fluorometric microscopy (QFM) of ezrin, indicating that calpain recruits ezrin to BB microvilli. Calpain inhibitors ZLLYCHN2, MDL 28170, and PD 150606 block BB assembly and ezrin recruitment to the BB. The HIV protease inhibitor ritonavir, which inhibits calpain at clinically relevant concentrations, also blocks BB assembly, whereas cathepsin and proteasome inhibitors do not. Microvillus effacement is inhibited after exposure of calpastatin-overexpressing cells to enteropathogenic Escherichia coli. These results suggest that calpain regulates BB assembly as well as pathological effacement, and indicate that it is an important regulator involved in HIV protease inhibitor toxicity and host-microbial pathogen interactions.
AB - This study identifies calpain as being instrumental for brush border (BB) microvillus assembly during differentiation and effacement during bacterial pathogenesis. Calpain activity is decreased by 25-80% in Caco 2 lines stably overexpressing calpastatin, the physiological inhibitor of calpain, and the effect is proportional to the calpastatin/calpain ratio. These lines exhibit a 2.5-fold reduction in the rate of microvillus extension. Apical microvillus assembly is reduced by up to 50%, as measured by quantitative fluorometric microscopy (QFM) of ezrin, indicating that calpain recruits ezrin to BB microvilli. Calpain inhibitors ZLLYCHN2, MDL 28170, and PD 150606 block BB assembly and ezrin recruitment to the BB. The HIV protease inhibitor ritonavir, which inhibits calpain at clinically relevant concentrations, also blocks BB assembly, whereas cathepsin and proteasome inhibitors do not. Microvillus effacement is inhibited after exposure of calpastatin-overexpressing cells to enteropathogenic Escherichia coli. These results suggest that calpain regulates BB assembly as well as pathological effacement, and indicate that it is an important regulator involved in HIV protease inhibitor toxicity and host-microbial pathogen interactions.
UR - http://www.scopus.com/inward/record.url?scp=0042029685&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042029685&partnerID=8YFLogxK
U2 - 10.1074/jbc.M304616200
DO - 10.1074/jbc.M304616200
M3 - Article
C2 - 12764139
AN - SCOPUS:0042029685
SN - 0021-9258
VL - 278
SP - 30403
EP - 30412
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 32
ER -